Home Applications 211172 Application 211172
Type NDA
Sponsor AKCEA THERAPS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TEGSEDI INOTERSEN SODIUM SOLUTION;SUBCUTANEOUS EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211172-001 TEGSEDI INOTERSEN SODIUM EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD 2018-10-05
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N211172-001 8697860 2031-04-29 Drug product 2018-11-01 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 N211172-001 9399774 2031-04-29 U-2430 2018-11-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N211172-001 TEGSEDI EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2018-10-05 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N211172-001 TEGSEDI EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2018-10-05 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N211172-001 TEGSEDI EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2018-10-05 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N211172-001 TEGSEDI EQ 284MG BASE/1.5ML (EQ 189.3MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD 2018-10-05 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 6 · 219 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 c2088c7a36db…2026-09-14 22:38:34 2026-08 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211172-001 8101743 2025-04-01 Drug substance, Drug product 2018-11-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211172-001 8101743 2025-04-01 Drug substance, Drug product 2018-11-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211172-001 8101743 2025-04-01 Drug substance, Drug product 2018-11-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211172-001 8101743 2025-04-01 Drug substance, Drug product 2018-11-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211172-001 8101743 2025-04-01 Drug substance, Drug product 2018-11-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211172-001 8101743 2025-04-01 Drug substance, Drug product 2018-11-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211172-001 8101743 2025-04-01 Drug substance, Drug product 2018-11-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211172-001 8697860 2031-04-29 Drug product 2018-11-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211172-001 9061044 2031-04-29 Drug substance 2018-11-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211172-001 9399774 2031-04-29 U-2430 2018-11-01 5bbf6a4d5a75…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 63 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current 72126-007 Tegsedi inotersen Akcea Therapeutics, Inc. NDA Current